-
Sarepta Therapeutics (NASDAQ:SRPT) Earns "Buy" Rating from Needham & Company LLC
ソース: Buzz FX / 14 1 2025 07:36:16 America/Chicago
Sarepta Therapeutics (NASDAQ:SRPT) Earns "Buy" Rating from Needham & Company LLC Written by MarketBeat January 14, 2025 Share Link copied to clipboard. Sarepta Therapeutics ( NASDAQ:SRPT - Get Free Report ) 's stock had its "buy" rating rei
Read more...